Isolation and regulation of the cGMP-inhibited cAMP phosphodiesterase in human erythroleukemia cells

Thrombosis and Haemostasis

Volumn 77, Issue 1, 1997, Pages 155-162

  Sheth, S B ^a   Brennan, K J ^a   Biradavolu, R ^a   Colman, R W ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE ACTIVATOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP PHOSPHODIESTERASE; CYCLIC GMP; CYCLOHEXIMIDE; DACTINOMYCIN; FORSKOLIN; THROMBOCYTE ENZYME;

ARTICLE; CARDIOVASCULAR SYSTEM; CELL MATURATION; CONTROLLED STUDY; ENZYME ISOLATION; ENZYME KINETICS; ENZYME REGULATION; ERYTHROLEUKEMIA; HEMATOPOIETIC CELL; HUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION;

EID: 0031047666     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1655924     Document Type: Article

References (33)

1. Hidaka H, Endo T. Human blood platelet 3'5'-cyclic nucleotide phosphodiesterase. Isolation of low-km and high-km phosphodiesterase. Biochim Biophys Acta 1976; 429: 485-97.
2. Sheth SB, Colman RW. Regulatory and catalytic domains of platelet cAMP phosphodiesterases: targets for drug design. [Review]. Semin Heme 1996; 110-9.
3. Grant PG, Colman RW. Purification and characterization of a human platelet cyclic nucleotide phosphodiesterase. Biochem 1984; 23: 1801-7.
4. Honerjager P. Pharmacology of positive inotropic phosphodiesterase III inhibitors. Eur Heart J 1989; 10 Suppl C: 25-31.
5. Weishaar RE, Kobylarz-Singer DC, Kaplan HR. Subclasses of cyclic AMP phosphodiesterase in cardiac muscle. J Mol Cell Card 1987; 19: 1025-36.
6. Weishaar RE, Kobylarz-Singer DC, Quade MM, Steffen RP, Kaplan HR. Multiple molecular forms of phosphodiesterase and the regulation of cardiac muscle contractility. J Cyc Nuc Prot Phos Res 1986; 11: 513-27.
7. Weishaar RE, Burrows SD, Kobylarz DC, Quade MM, Evans DB. Multiple molecular forms of cyclic nucleotide phosphodiesterase in cardiac and smooth muscle and in platelets. Isolation, characterization, and effects of various reference phosphodiesterase inhibitors and cardiotonic agents. Biochem Pharm 1986; 35: 787-800.
8. Suttorp N, Weber U, Welsch T, Schudt C. Role of phosphodiesterases in the regulation of endothelial permeability in vitro. J Clin Invest 1993; 91: 1421-8.
9. Degerman E, Moos M Jr., Rascón A, Vasta V, Meacci E, Smith CJ, Lingren S, Andersson K-E, Belfrage P, Manganiello V. Single-step affinity purification, partial structure and properties of human platelet cGMP inhibited cAMP phosphodiesterase. Biochim Biophys Acta Protein Struct Mol Enzymol 1994; 1205: 189-98.
10. Charbonneau H. Structure-function relationships among cyclic nucleotide phophodiesterases. In: Cyclic Nucleotide Phosphodiesterases: Structure, Regulation and Drug Action. Beavo J, Houslay MD (eds). New York: John Wiley and Sons, 1990: pp 267-96.
11. Tabilio A, Rosa JP, Testa U, Kieffer N, Nurden AT, Del Canizo MC, Breton-Gorius J, Vainchender W. Expression of platelet membrane glycoproteins and α-granule proteins by a human erythroleukemia cell line (HEL). EMBO J 1984; 3: 453-9.
12. Ashby B, Almonor GO, Wernick E, Selak MA. Prostaglandin-concentration-dependent desensitization of adenylate cyclase in human erythroleukaemia (HEL)cells is abolished by pertussis toxin and enhanced by induction by dimethyl sulphoxide. Biochem J 1991; 280: 801-4.
13. Macphee CH, Reifsnyder DH, Moore TA, Beavo JA. Intact cell and cell-free phosphorylation and concomitant activation of a low Km, cAMP phosphodiesterase found in human platelets. J Cyc Nuc Prot Phos Res 1986; 11: 487-96.
14. Grant PG, Mannarino AF, Colman RW. cAMP-mediated phosphorylation of the low-Km cAMP phosphodiesterase markedly stimulates its catalytic activity. Proc Natl Acad Sci USA 1988; 85: 9071-5.
15. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
16. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350-4.
17. 2. Implications for the therapeutic use of beta-adrenoceptor agonists. J Biol Chem 1996; 270: 23598-604.
18. Sinha AK, Shattil SJ, Colman RW. Cyclic AMP metabolism in cholesterolrich platelets. J Biol Chem 1977; 252: 3310-4.
19. Torphy TJ, Cieslinski LB. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle. Mol Pharmacol 1990; 37: 206-14.
20. Thompson WJ, Terasaki WL, Epstein PM, Strada SJ. Assay of cyclic nucleotide phosphodiesterase and resolution of multiple molecular forms of the enzyme [Review]. Adv Cyc Nuc Res 1979; 10: 69-92.
21. Macphee CH, Reifsnyder DH, Moore TA, Lerea KM, Beavo JA. Phosphorylation results in activation of a cAMP phosphodiesterase in human platelets. J Biol Chem 1988; 263: 10353-8.
22. Macphee CH, Harrison SA, Beavo JA. Immunological identification of the major platelet low-Km cAMP phosphodiesterase: probable target for anti-thrombotic agents. Proc Natl Acad Sci USA 1986; 83: 6660-3.
23. Rascon A, Degerman E, Taira M, Meacci E, Smith CJ, Manganiello V, Belfrage P, Tornqvist H. Identification of the phosphorylation site in vitro for cAMP-dependent protein kinase on the rat adipocyte cGMP-inhibited cAMP phosphodiesterase. J Biol Chem 1994; 269: 11962-6.
24. Rahn T, Ronnstrand L, Leroy MJ, Wernsted C, Tornqvist H, Manganiello VC, Belfrage P, Degerman E. Identification of the site in the cGMP-inhibited phosphodiesterase phosphorylated in adipocytes in response to insulin and isoproterenol. J Biol Chem 1996; 271: 11575-80.
25. Sette C, Vicini E, Conti M. The ratPDE3/IVd phosphodiesterase gene codes for multiple proteins differentially activated by cAMP-dependent protein kinase [published erratum appears in J Biol Chem 1994 Aug 12; 269(32): 20806]. J Biol Chem 1994; 269: 18271-4.
26. Gettys TW, Blackmore PF, Redmon JB, Beebe SJ, Corbin JD. Short-term feedback regulation of cAMP by accelerated degradation in rat tissues. J Biol Chem 1987; 262: 333-9.
27. Cheung P, Xu H, McLaughlin MM, Ghazeleh FA, Livi GP, Colman RW. Human platelet cGI-PDE: Expression in yeast and localization of the catalytic domain by deletion mutagenesis. Blood 1996; 88: 1321-9.
28. Meacci E, Taira M, Moos M Jr., Smith CJ, Movsesian MA, Degerman E, Belfrage P, Manganiello V. Molecular cloning and expression of human myocardial cGMP-inhibited cAMP phosphodiesterase. Proc Natl Acad Sci USA 1992; 89: 3721-5.
29. Taira M, Hockman SC, Calvo JC, Belfrage P, Manganiello VC. Molecular cloning of the rat adipocyte hormone-sensitive cyclic GMP-inhibited cyclic nucleotide phosphodiesterase. J Biol Chem 1993; 268: 18573-9.
30. Mochly-Rosen D. Localization of protein kinases by anchoring proteins: a theme in signal transduction. [Review]. Science 1995; 268: 247-51.
31. Richardson MD, Goka TJ, Barber R, Butcher RW. Growth of S49 wild type cells in 3 nM epinephrine increases cyclic AMP phosphodiesterase activity. Life Sciences 1994; 54: 863-75.
32. Torphy TJ, Zhou HL, Cieslinski LB. Stimulation of beta adrenoceptors in a human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity. J Pharmacol Exp Ther 1992; 263: 1195-205.
33. Mazur EM, Rosmarin AG, Sohl PA, Newton JL, Narendran A. Analysis of the mechanism of anagrelide-induced thrombocytopenia in humans. Blood 1992; 79: 1931-7.